Flowers Foods Q2 Earnings Beat Estimates, FY25 Forecast Trimmed

Flowers Foods (FLO) reported mixed fiscal Q2 2025 results, with adjusted EPS of $0.30 beating estimates but declining year-over-year, while sales of $1.24 billion missed consensus despite a 1.5% increase, largely due to a decline in price/mix and volumes. Citing lower-than-expected Q2 sales, ongoing bread category pressures, and intense competition, management significantly lowered its full-year fiscal 2025 guidance for net sales, adjusted EBITDA, and adjusted EPS. This revised outlook underscores persistent operational headwinds and has contributed to the stock's recent underperformance and its Zacks Rank #4 (Sell) rating.

Analysis

Flowers Foods reported a challenging second quarter for fiscal 2025, with results characterized by a significant downward revision of full-year guidance that overshadowed a narrow earnings beat. While adjusted EPS of $0.30 surpassed the consensus estimate of $0.29, it marked a notable decline from $0.36 in the prior-year quarter. More critically, the 1.5% year-over-year sales growth to $1.24 billion, which missed estimates, was entirely attributable to the Simple Mills acquisition (+5.1%). This masked a concerning organic decline, with price/mix falling 1.2% and volumes dropping 2.4%, signaling weakening consumer demand and pricing power amid intense competition. Profitability also deteriorated, with adjusted EBITDA decreasing 4% to $137.7 million and the adjusted EBITDA margin contracting by 60 basis points to 11.1%. In response to these pressures, management lowered its full-year 2025 forecast for sales, adjusted EBITDA, and adjusted EPS, with the new EPS range of $1.00-$1.10 representing a substantial drop from the $1.28 delivered in fiscal 2024. This negative outlook is compounded by the stock's recent 8.5% decline over three months, underperforming its industry, and a Zacks Rank #4 (Sell) rating.

Key Decisions for Investors

• The significant reduction in FY25 guidance for sales, EBITDA, and EPS warrants a cautious or bearish re-evaluation of the stock's prospects, as it signals that management expects operational headwinds from competition and weak demand to persist.
• Investors should look beyond the headline sales growth and focus on the deteriorating organic performance, where both pricing and volumes are in decline, as this is a key indicator of the fundamental health of the core business.
• Given the company's operational challenges and stock underperformance, consider evaluating relative opportunities in peers such as Post Holdings (POST) and Smithfield Foods (SFD), which the report cites as having stronger growth outlooks and analyst ratings.